Eurofins Ramps up Its Multi-Million Laboratory Network Upgrade in Australia and New Zealand
15 December 2014 - 5:30PM
Business Wire
Regulatory News:
Eurofins (Paris:ERF):
Eurofins Scientific (EUFI.PA), the global leader in food and
environment testing, announces the acceleration of its
modernisation and expansion program to bring its laboratories
across Australia and New Zealand to world-class standards, and
provide its clients in the region the same standards and
capabilities that have come to define Eurofins in other parts of
the world. The ca. AUD 15m (ca. EUR 10m) investment programme,
which commenced in January 2013 includes the extensive upgrade of
7,300m2 of laboratory surface in the Group’s 7 laboratories and 12
agroscience sites in the region, the construction of a brand new
600m2 laboratory Christchurch, NZ, in addition to the new
state-of-the-art quarantine facility in Toowoomba, QLD, announced
in September.
The comprehensive upgrade of 3,600m2 laboratory surface in
Sydney and Melbourne closely follows the completion of the 3,700m2
extensive rebuild of Eurofins’ main site in Auckland, New Zealand
earlier this year. The modernisation program will continue in 2015
with the construction of a brand new 600m2 site in Rolleston
Christchurch, further underscoring the Group’s commitment to the
Food and Dairy segments in the South Island of New Zealand. The new
facility is expected to be completed in April 2015.
Eurofins also brought together its Rozelle and Orange sites into
a new, large facility in Lane Cove, to consolidate its competencies
in agrochemical and veterinary medicine GLP studies, as well as
routine pesticide and herbicide analysis. In addition, Eurofins has
established three competence centers for the analyses of Asbestos
(Sydney), SPOCAS (Brisbane) and AFF-PFOS (Brisbane), all of which
are NATA-accredited.
The modernised laboratories boast state-of-the-art equipment and
instrumentation, consistent with the Group’s laboratories in Europe
and the US, designed for optimal efficiency, allowing Eurofins to
continue to deliver the highest-quality of analytical services at
industry-beating turnaround times (TAT).
Comment from Dr. Matthias-Wilbur Weber, Eurofins Group
Executive Vice President for Asia Pacific: “The investments
Eurofins has poured into our laboratories in Australia and New
Zealand is a further demonstration of our plans to accelerate our
network build-up in the overall region, and reflects our commitment
to further strengthen our Asia Pacific footprint. We intend to
continue to extend the full capabilities of the Eurofins Group to
benefit our clients in Asia Pacific, and look forward to becoming
the laboratory partner of choice for the food and environmental
industries in the region”.
For more information please visit
http://www.eurofins.com.au
Notes for the editor:
Eurofins – a global leader in bio-analysis
Eurofins Scientific is the world leader in food and
pharmaceutical products testing. It is also number one in the world
in the field of environmental laboratory services and one of the
global market leaders in agroscience, genomics, discovery
pharmacology and central laboratory services.
With over 16,000 staff in more than 200 laboratories across 36
countries, Eurofins offers a portfolio of over 100,000 reliable
analytical methods for evaluating the safety, identity,
composition, authenticity, origin and purity of biological
substances and products. The Group provides its customers with
high-quality services, accurate results in time and expert advice
by its highly qualified staff.
Eurofins is committed to pursuing its dynamic growth strategy by
expanding both its technology portfolio and its geographic reach.
Through R&D and acquisitions, the Group draws on the latest
developments in the field of biotechnology and analytical chemistry
to offer its clients unique analytical solutions and the most
comprehensive range of testing methods.
As one of the most innovative and quality oriented international
players in its industry, Eurofins is ideally positioned to support
its clients’ increasingly stringent quality and safety standards
and the expanding demands of regulatory authorities around the
world.
The shares of Eurofins Scientific are listed on the Euronext
Paris Stock Exchange (ISIN FR0000038259, Reuters EUFI.PA, Bloomberg
ERF FP).
Important disclaimer:
This press release contains forward-looking statements and
estimates that involve risks and uncertainties. The forward-looking
statements and estimates contained herein represent the judgement
of Eurofins Scientific’ management as of the date of this release.
These forward-looking statements are not guarantees for future
performance, and the forward-looking events discussed in this
release may not occur. Eurofins Scientific disclaims any intent or
obligation to update any of these forward-looking statements and
estimates. All statements and estimates are made based on the data
available to the Company as of the date of publication, but no
guarantee can be made as to their validity.
Eurofins | mgtSefton McGraw, +61 3 8564 5002Managing
Directorseftonmcgraw@eurofins.com.auorManaging Director, Eurofins
Agroscience TestingSusan McKeon, + 61 2
99008449susanmckeon@eurofins.com.au
Enerplus (NYSE:ERF)
Historical Stock Chart
From Jun 2024 to Jul 2024
Enerplus (NYSE:ERF)
Historical Stock Chart
From Jul 2023 to Jul 2024